Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06272864 · ClinicalTrials.gov registry record
BostonGene and Exigent Genomic INsight Study
A clinical trial of Breast Cancer and Non-Small Cell Lung Cancer, sponsored by BostonGene.
- Recruiting
- Registry status
- 400
- Enrollment target
- 7
- Study locations
NCT06272864 is a study of Breast Cancer and Non-Small Cell Lung Cancer that is actively recruiting participants, run by BostonGene. The registered enrollment target is 400 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (86% lower). The trial reports 7 study locations across 7 states.
The verdict
NCT06272864, a study of Breast Cancer and Non-Small Cell Lung Cancer, is actively recruiting participants, sponsored by BostonGene.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 7
- Study locations
Study Summary
The BEGIN Study by BostonGene and Exigent Genomic INsight evaluates the efficacy of comprehensive molecular testing in advanced cancer patients. Using the BostonGene Tumor Portrait test, the study aims to identify actionable findings, assess feasibility, and determine patient enrollment in clinical trials. Four cohorts of 100 patients each will be studied over two years, focusing on treatment decisions and patient outcomes. This study seeks to demonstrate the clinical utility of genomic testing in guiding therapy for advanced cancer patients in community settings.
Conditions Studied
Study Locations (7)
Arkansas
- Highlands Oncology Group - Rogers
California
- Stockton Hematology Oncology Medical Group - Stockton
Indiana
- Fort Wayne Medical Oncology and Hematology - Fort Wayne
New Mexico
- New Mexico Cancer Center - Albuquerque
Oklahoma
- Oklahoma Cancer Specialists and Research Institute - Tulsa
Texas
- Oncology Consultants - Houston
Washington
- Northwest Medical Specialities - Puyallup
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2024-04-08 |
| Est. Completion | 2028-01-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06272864
The ClinicalTrials.gov registry entry for NCT06272864 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (86% lower). The listed sponsor is BostonGene, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT06272864 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Arkansas, California, Indiana.
Frequently Asked Questions
What is clinical trial NCT06272864 about?
NCT06272864 is a clinical study titled "BostonGene and Exigent Genomic INsight Study". The BEGIN Study by BostonGene and Exigent Genomic INsight evaluates the efficacy of comprehensive molecular testing in advanced cancer patients. Using the BostonGene Tumor Portrait test, the study aims to identify actionable findings, assess feasibility, and determine patient enrollment in clinical ...
What is the current status of trial NCT06272864?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2024-04-08. Estimated completion is 2028-01-08.
What conditions does trial NCT06272864 study?
This clinical trial studies the following conditions: Breast Cancer, Non-Small Cell Lung Cancer, Melanoma, Sarcoma.
Who is sponsoring clinical trial NCT06272864?
This trial is sponsored by BostonGene, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06272864 being conducted?
This trial has 7 study locations across Arkansas, California, Indiana, New Mexico, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.